Phosphatidylinositol-3-Kinase/Akt Regulates Bleomycin-Induced Fibroblast Proliferation and Collagen Production
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Abnormal repair and dysregulated angiogenesis have been implicated in the pathogenesis of pulmonary fibrosis, but the underlying mechanisms of regulation are not well understood. The present study investigated the role of phosphatidylinositol-3-kinase (PI3K)/Akt in fibrogenesis of human lung fibroblasts and its regulation by reactive oxygen species (ROS). Exposure of lung fibroblasts to bleomycin, a known inducer of fibrosis, resulted in rapid activation of PI3K/Akt and a parallel increase in fibroblast proliferation and collagen production, characteristics of lung fibrosis. Bleomycin had no significant effect on total Akt protein expression but induced phosphorylation of the protein at threonine 308 and serine 473 positions. Inhibition of this phosphorylation by PI3K inhibitors or by dominant-negative Akt (T308A/S473A) expression abrogated the effects of bleomycin on fibroblast proliferation and collagen production, suggesting the role of PI3K/Akt in the fibrogenic process. Activation of PI3K/Akt by bleomycin also led to transcriptional activation and protein expression of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor, which contributed to the fibroproliferative and collagen-inducing effects of bleomycin. The fibrogenic effects of bleomycin were dependent on ROS generation, particularly superoxide anion and hydrogen peroxide, which were induced by bleomycin. Inhibition of ROS generation by antioxidant enzymes, catalase and superoxide dismutase mimetic MnTBAP, abrogated the fibrogenic effects of bleomycin as well as its induction of PI3K/Akt and HIF-1α activation. Together, our results indicate a novel role of PI3K/Akt in fibrogenesis of human lung fibroblasts and its regulation by ROS, which could be exploited for the treatment of pulmonary fibrosis and related disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Overexpression of SMAD3 enhances, whereas knockdown inhibits αSMA and extracellular matrix production in fibroblasts (45–48). Furthermore, fibroblast-specific deletion of SMAD3 reduces αSMA production and myofibroblast phenotype (49–52), for example, loss of SMAD3 lowers the number of activated myofibroblasts in cardiac fibrosis in vivo and reduces extracellular matrix production by myofibroblasts”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tacchini, L. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh227 · Cited by 112
RetractedWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · cited 2×
“Consistent with previous reports showing the regulatory role of HIF-1a on VEGF expression (26, 27, 47), we found that VEGF gene and protein expression was also up-regulated by the bleomycin treatment and that this effect can be inhibited by the PI3K inhibitor LY294002 (Figures 4A–4C).”
BackgroundResultSelf-citationThe phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621 · cited 2×
“The PI3K/Akt pathway is involved in many cellular processes, including cell growth, differentiation, apoptosis, and angiogenesis (14, 15), and is commonly triggered by the activation of receptor tyrosine kinases, which leads to the translocation of PI3K from cytoplasm to plasma membrane.”
BackgroundMechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Self-citationSelman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,668
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
(2000) · PubMed · Cited by 1,445
Targeting the PI3K-Akt pathway in human cancer
Luo, J., Manning, B. D., & Cantley, L. C. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00248-4 · Cited by 1,290
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Jiang, B. H., Semenza, G. L., Bauer, C., & Marti, H. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.4.c1172 · Cited by 1,213 · cited 2×
“Consistent with previous reports showing the regulatory role of HIF-1a on VEGF expression (26, 27, 47), we found that VEGF gene and protein expression was also up-regulated by the bleomycin treatment and that this effect can be inhibited by the PI3K inhibitor LY294002 (Figures 4A–4C).”
BackgroundResultSelf-citationMatrix metalloproteinases: a tail of a frog that became a prince
Brinckerhoff, C. E., & Matrisian, L. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm763 · Cited by 1,105
Liu, Y., Cox, S. R., Morita, T., & Kourembanas, S. (1995) · Circulation Research · doi:10.1161/01.res.77.3.638 · Cited by 1,040
Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L., & Arteaga, C. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005912200 · Cited by 992
Cloning of a Factor Required for Activity of the Ah (Dioxin) Receptor
Hoffman, E. C., Reyes, H., Chu, F.-F., Sander, F., Conley, L. H., Brooks, B. A., & Hankinson, O. (1991) · Science · doi:10.1126/science.1852076 · Cited by 957
The epidemiology of interstitial lung diseases.
Coultas, D. B., Zumwalt, R. E., Black, W. C., & Sobonya, R. E. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.4.7921471 · Cited by 946
Mechanisms of Pulmonary Fibrosis
Thannickal, V. J., Toews, G. B., White, E. S., Lynch III, J. P., & Martinez, F. J. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103810 · Cited by 808
Richard, D. E., Berra, E., Gothié, E., Roux, D., & Pouysségur, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32631 · Cited by 790
High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis
Raghu, G., Freudenberger, T. D., Yang, S., Curtis, J. R., Spada, C., Hayes, J., Sillery, J. K., Pope, C. E., & Pellegrini, C. A. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00037005 · Cited by 643
Idiopathic Pulmonary Fibrosis: Relationship between Histopathologic Features and Mortality
KING, T. E., SCHWARZ, M. I., BROWN, K., TOOZE, J. A., COLBY, T. V., WALDRON, J. A., FLINT, A., THURLBECK, W., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.6.2001056 · Cited by 628
(2001) · PubMed · Cited by 557
Self-citationJiang, B.-H., Zheng, J. Z., Aoki, M., & Vogt, P. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040560897 · Cited by 528
Self-citationKuhn, C., & McDonald, J. A. (1991) · PubMed · Cited by 472
Yang, E. Y., & Moses, H. L. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.731 · Cited by 464
ERK activation upon hypoxia: involvement in HIF‐1 activation
Minet, E., Arnould, T., Michel, G., Roland, I., Mottet, D., Raes, M., Remacle, J., & Michiels, C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01181-9 · Cited by 379
Pathobiology of pulmonary fibrosis
Crouch, E. (1990) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1990.259.4.l159 · Cited by 322
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
Hamada, K., Sasaki, T., Koni, P. A., Natsui, M., Kishimoto, H., Sasaki, J., Yajima, N., Horie, Y., Hasegawa, G., Naito, M., et al. (2005) · Genes & Development · doi:10.1101/gad.1308805 · Cited by 287
MMP-1: the elder of the family
Pardo, A., & Selman, M. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.06.017 · Cited by 268 · cited 7×
“Keywords: collagen; bleomycin; PI3K; Akt; ROS Pulmonary fibrosis is a progressive and lethal lung disease characterized by excessive proliferation of fibroblasts and deposition of extracellular matrix (ECM) (1, 2).”
BackgroundInfluentialMoule, S. K., Welsh, G. I., Edgell, N. J., Foulstone, E. J., Proud, C. G., & Denton, R. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7713 · Cited by 244
R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways
Cao, Y., Cao, R., & Hedlund, E.-M. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0337-z · Cited by 215
Direct targets of phosphoinositide 3-kinase products in membrane traffic and signal transduction
Corvera, S. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01366-x · Cited by 206
Gao, N., Ding, M., Zheng, J. Z., Zhang, Z., Leonard, S. S., Liu, K. J., Shi, X., & Jiang, B.-H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200082200 · Cited by 191
Self-citationFlaherty, K. R., Toews, G. B., Lynch, J. P., Kazerooni, E. A., Gross, B. H., Strawderman, R. L., Hariharan, K., Flint, A., & Martinez, F. J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00711-7 · Cited by 184
Progressive pulmonary fibrosis is mediated by TGF-β isoform 1 but not TGF-β3
Ask, K., Bonniaud, P., Maass, K., Eickelberg, O., Margetts, P. J., Warburton, D., Groffen, J., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.016 · Cited by 172
Regulation of Antioxidant Enzymes in Lung after Oxidant Injury
Quinlan, T. R., Spivack, S. D., & Mossman, B. T. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.9410279 · Cited by 142
Gong, P., Hu, B., Stewart, D., Ellerbe, M., Figueroa, Y. G., Blank, V., Beckman, B. S., & Alam, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103658200 · Cited by 140
Gao, N., Shen, L., Zhang, Z., Leonard, S. S., He, H., Zhang, X., Shi, X., & Jiang, B. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000007259.65742.16 · Cited by 136
Self-citationGharaee‐Kermani, M., Gyetko, M. R., Hu, B., & Phan, S. H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9216-x · Cited by 112
Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis.
Selman, M., Montano, M., Ramos, C., & Chapela, R. (1986) · Thorax · doi:10.1136/thx.41.5.355 · Cited by 96
Fehrenbach, H., Kasper, M., Haase, M., Schuh, D., & M�ller, M. (1999) · The Anatomical Record · doi:10.1002/(sici)1097-0185(19990101)254:1<61::aid-ar8>3.0.co;2-d · Cited by 95
Meyer, K. C., Cardoni, A. L., & Xiang, Z. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.105618 · Cited by 94
Sable, C. L., Filippa, N., Filloux, C., Hemmings, B. A., & Van Obberghen, E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29600 · Cited by 59
Clark, R. A., Mason, R. J., Folkvord, J. M., & McDonald, J. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112509 · Cited by 54
Yamamoto, T., Eckes, B., & Krieg, T. (2000) · Archives of Dermatological Research · doi:10.1007/s004030000180 · Cited by 53
In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis
Inghilleri, S., Morbini, P., Oggionni, T., Barni, S., & Fenoglio, C. (2005) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0116-7 · Cited by 50
Steurer, M., Zoller, H., Augustin, F., Fong, D., Heiss, S., Strasser‐Weippl, K., Gastl, G. A., & Tzankov, A. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.12.011 · Cited by 48
Emerging Information Management Technologies and the Future of Disease Management
Nobel, J. J., & Norman, G. K. (2003) · Disease Management · doi:10.1089/109350703322682531 · Cited by 33
Hellwig‐Bürgel, T., Stiehl, D. P., Katschinski, D. M., Marxsen, J. H., Kreft, B., & JELKMANN, W. E. B. (2005) · Cellular Physiology and Biochemistry · doi:10.1159/000083642 · Cited by 22
Yen, H., Chang, H., Majima, H. J., Chen, F.-Y., & Li, S.-H. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.12.022 · Cited by 21
Angiogenesis and Anti-angiogenic Therapy in Myelofibrosis with Myeloid Metaplasia
Arora, B., Mesa, R. A., & Tefferi, A. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190400003267 · Cited by 15
Roymans, D., Grobben, B., Claes, P., & Slegers, H. (2001) · Cell Biology International · doi:10.1006/cbir.2000.0636 · Cited by 14
Koslowski, R., Morgner, J., Seidel, D., Knoch, K.-P., & Kasper, M. E. (2004) · Experimental and Toxicologic Pathology · doi:10.1078/0940-2993-00343 · Cited by 5
Research works printed but not linked: 1
- 9. FlahertyKR,ToewsGB,LynchJPIII,KazerooniEA,GrossBH,Strawderman RL, Hariharan K, Flint A, Martinez FJ. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. AmJMed 2001;110:278-282.
Cited by
Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
Wang, J., Hu, K., Cai, X., Yang, B., He, Q., Wang, J., & Weng, Q. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.023 · Cited by 450
Autophagy in Idiopathic Pulmonary Fibrosis
Patel, A. S., Lin, L., Geyer, A., Haspel, J. A., An, C. H., Cao, J., Rosas, I. O., & Morse, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041394 · Cited by 372
The Akt pathway in oncology therapy and beyond (Review)
Nitulescu, G., Van De Venter, M., Nitulescu, G., Ungurianu, A., Juzenas, P., Peng, Q., Olaru, O., Grădinaru, D., Tsatsakis, A., Tsoukalas, D., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4597 · Cited by 328
Hsu, H.-S., Liu, C.-C., Lin, J.-H., Hsu, T.-W., Hsu, J.-W., Su, K., & Hung, S.-C. (2017) · Scientific Reports · doi:10.1038/s41598-017-14612-5 · Cited by 205
Jun, E., Zhang, Q., Yoon, B., Moon, J.-H., Lee, G., Park, G., Kang, P., Lee, J., Kim, A., & You, S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15010605 · Cited by 176
Metadata
- Authors
- Lu, Y., Azad, N., Wang, L., Iyer, A. K. V., Castranova, V., Jiang, B.-H., & Rojanasakul, Y.
- Affiliations
- Department of Pharmaceutical Sciences and
- Hampton University (US)
- National Institute for Occupational Safety and Health (US)
- West Virginia University (US)
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-01
- Volume
- 42
- Issue
- 4
- Pages
- 432-441
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- PMC
- PMC2848736
- OpenAlex
- W2153557413
- Cited by
- 138
- References
- 53
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 13 · 2022: 13 · 2021: 10 · 2020: 15 · 2019: 5 · 2018: 7 · 2017: 10 · 2016: 5 · 2015: 10 · 2014: 6 · 2013: 7 · 2012: 6
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01-HL76340, R01HL076340)
- National Institute for Occupational Safety and Health
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- phosphatidylinositol 3-kinase/Akt signaling, pulmonary fibrosis, bleomycin, lung fibroblasts, fibroblast proliferation, collagen synthesis, reactive oxygen species, superoxide, hydrogen peroxide, hypoxia-inducible factor-1α, vascular endothelial growth factor, Akt phosphorylation, catalase, fibrogenesis
- MeSH terms
- Phosphoinositide-3 Kinase Inhibitors, Antibiotics, Antineoplastic, Antioxidants, Bleomycin, Cell Line, Collagen, Enzyme Activation, Enzyme Inhibitors, Fibroblasts, Humans, Lung, Neovascularization, Pathologic, Oxidoreductases, Phosphorylation, Pulmonary Fibrosis, Transcription, Genetic, Reactive Oxygen Species, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.